127842
Last Update Posted: 2014-04-24
Recruiting has ended
All Genders accepted | 18 Years + |
110 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®)
The overall objective of the study was to describe the long-term effectiveness and safety of etanercept in patients with psoriatic arthritis in a Canadian clinical practice setting.
Eligibility
Relevant conditions:
Psoriatic Arthritis
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov